Xcout IntelSolarea Bio, Inc.
Solarea Bio, Inc. is a biotechnology company that develops solutions for health disorders using bacteria and fungi native to healthy foods.
Subscribe to see Solarea Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Solarea Bio, Inc. at a glance
Solarea Bio, Inc. is a biotechnology company headquartered in United States. It has raised at least $52.2M across the 5 funding rounds on record. Its most recent funding round raised $9.9M in November 2025. Xcout tracks 9 named people at Solarea Bio, Inc., including ERIC SCHOTT (CHIEF OPERATING OFFICER).
Solarea Bio, Inc. leadership
- ERIC SCHOTTCHIEF OPERATING OFFICER
- Catherine Balsam-SchwaberExecutive Officer
- ERIC SCHOTTExecutive Officer
- GERARDO TOLEDOExecutive Officer
- ILISSA LARIMOREExecutive Officer
- Anula JayasuriyaDirector
3 more named people on record for Solarea Bio, Inc., with roles, board committees and tenure — see the full roster →
Solarea Bio, Inc. funding rounds
At least $52.2M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9.9M | — | |
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $15M | — | |
| Series B | $15M | 4 named | |
| — | $11.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Solarea Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Solarea Bio, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access